SPRING BANK PHARMACEUTICALS, INC.

Profile

Company Names

SPRING BANK PHARMACEUTICALS, INC.

Addresses

86 SOUTH STREET, HOPKINTON, MA 01748

113 CEDAR STREET, SUITE 7, MILFORD, MA 01757

Phone Numbers

508-473-5993

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$47,181,218.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2016-11-23 
$15,000,001.00 
$15,000,001.00 
$0.00 
Equity 
3
2014-12-31 
$21,647,967.00 
$21,647,967.00 
$0.00 
Equity 
2
2013-10-18 
$6,333,250.00 
$6,333,250.00 
$0.00 
Debt 
1
2012-09-14 
$4,200,000.00 
$8,000,000.00 
$3,800,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NEZAM 
 
AFDHAL 
EXECUTIVE OFFICER
SPRING BANK PHARMACEUTICALS, INC.
DAVID 
 
ARKOWITZ 
DIRECTOR
AEGERION PHARMACEUTICALS, INC.   |  MASCOMA CORP   |  VISTERRA, INC.   |  SPRING BANK PHARMACEUTICALS, INC.   |  YUMANITY THERAPEUTICS, INC.   |  KINETA, INC./DE   |  IBIO, INC.   |  HENDRIKLAAN 51, LLC
JONATHAN 
 
BATES 
DIRECTOR
SPRING BANK PHARMACEUTICALS, INC.   |  INNOVATIVE DIGITAL INVESTORS EMERGING TECHNOLOGY, LP   |  MAMAMEND INC   |  INNOVATIVE SPAC ARBITRAGE, L.P.   |  BITMINE IMMERSION TECHNOLOGIES, INC.   |  POWERFLEET, INC.
JONATHAN 
ELLSWORTH 
BATES 
DIRECTOR
SPRING BANK PHARMACEUTICALS, INC.
JONATHON 
ELLSWORTH 
BATES 
DIRECTOR
SPRING BANK PHARMACEUTICALS, INC.
GREGG 
 
BELOFF 
EXECUTIVE OFFICER
SPRING BANK PHARMACEUTICALS, INC.   |  CENTREXION THERAPEUTICS CORP   |  NEUROVANCE, INC.   |  CERULEAN PHARMA INC.   |  SG DAN HOLDINGS LLC
MICHAEL 
FRANCIS 
CRONIN 
EXECUTIVE OFFICER
SPRING BANK PHARMACEUTICALS, INC.
MARTIN 
 
DRISCOLL 
EXECUTIVE OFFICER, DIRECTOR
ASMACURE, INC.   |  SPRING BANK PHARMACEUTICALS, INC.   |  ONCONANO MEDICINE, INC.
KURT 
M. 
EICHLER 
DIRECTOR
MIMEDX GROUP, INC.   |  SPRING BANK PHARMACEUTICALS, INC.
JONATHAN 
 
FREVE 
EXECUTIVE OFFICER
SPRING BANK PHARMACEUTICALS, INC.
R.P. 
KRIS 
IYER 
DIRECTOR
SPRING BANK PHARMACEUTICALS, INC.
RADHAKRISHNAN 
PARAMESWARAN 
IYER 
EXECUTIVE OFFICER, DIRECTOR
SPRING BANK PHARMACEUTICALS, INC.
DOUGLAS 
JOHN 
JENSEN 
EXECUTIVE OFFICER, DIRECTOR
SPRING BANK PHARMACEUTICALS, INC.
GUY 
 
MACDONALD 
DIRECTOR
TETRAPHASE PHARMACEUTICALS INC   |  SPRING BANK PHARMACEUTICALS, INC.
DONALD 
MOORE 
MITCHELL 
EXECUTIVE OFFICER
SPRING BANK PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-11-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-11-23 
2015-02-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-31 
2015-01-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-31 
2014-02-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-10-18 
2013-01-25
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
 
2012-09-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
WILLIAM BLAIR + COMPANY, L.L.C.
1252
NONE
NONE
GILFORD SECURITIES
8076
NONE
NONE
BROCK CAPITAL GROUP
122156
NONE
NONE
CHRIS LAFFEY
122156